The successful development of new platform technology for the rapid point-of-care (POC) diagnosis of influenza and other respiratory conditions has widespread potential for the detection of a wide range of infectious diseases. Supported by Innovate UK’s Biomedical Catalyst Fund, OJ Bio has now successfully completed the prototype development of a new wireless POC diagnosis system that accurately and quickly identifies the presence of various disease types in a range of patient samples.
The innovative handheld technology developed by OJ Bio combines new test assays carried on a multichannel biochip with a special reading device and supporting diagnostic software that can be carried on a mobile app, PC or the device itself.
Importantly, the diagnostic device can be used at a patient’s bedside or other POC location, such as a GP surgery or pharmacy, with the results being available immediately and without samples being sent for laboratory analysis.[DA1] This capability also enables the device to be used in the patient’s home.
www.oj-bio.com